[Tupelo3]

A new open access, online-only, multidisciplinary research journal dedicated to highlighting the most important scientific advances in Parkinson’s disease research. The journal is published in partnership with the Parkinson's Disease Foundation (PDF) and Nature Publishing Group (NPG).

•This interdisciplinary journal is dedicated to publishing the finest and high-quality research on Parkinson’s disease

•The journal is online-only and open access

•The Editors-in-Chief are David Sulzer, PhD, Columbia University, USA and Professor K Ray Chaudhuri Dsc MD, King's College London, UK

•The journal will be open for submissions in early December

http://www.nature.com/npjparkd/

[pegleg]

Now we're talking! I am excited to see European and U.S. FDA agencies talk shop about current research. It behooves me how therapies such as Duodopa intestinal gel can be approved and used in Europe for years, and in the U.S. is still years away from approval. This is just one example of many, many questions many inset rested in research must have.

Thanks for sharing this, Tupelo!